|
61 |
IDH-mutant astrocytomas with primitive neuronal component have a distinct methylation profile and a higher risk of leptomeningeal spread
Enthalten in Acta neuropathologica Bd. 149, 3.2.2025, Nr. 1, date:6.2025: 1-13
|
|
|
|
62 |
Impact of 18F-FET PET on Target Volume Definition and Tumor Progression of Recurrent High Grade Glioma Treated with Carbon-Ion Radiotherapy
Enthalten in Scientific reports Bd. 8, 8.5.2018, Nr. 1, date:12.2018: 1-13
|
|
|
|
63 |
Impact of delays in initiating postoperative chemoradiation while determining the MGMT promoter-methylation statuses of patients with primary glioblastoma
Enthalten in BMC cancer Bd. 15, 30.7.2015, Nr. 1, date:12.2015: 1-7
|
|
|
|
64 |
Improvement of functional outcome for patients with newly diagnosed grade 2 or 3 gliomas with co-deletion of 1p/19q – IMPROVE CODEL: the NOA-18 trial
Enthalten in BMC cancer Bd. 22, 13.6.2022, Nr. 1, date:12.2022: 1-12
|
|
|
|
65 |
Integrated genetic analyses of immunodeficiency-associated Epstein-Barr virus- (EBV) positive primary CNS lymphomas
Enthalten in Acta neuropathologica Bd. 146, 26.7.2023, Nr. 3, date:9.2023: 499-514
|
|
|
|
66 |
INTERCEPT H3: a multicenter phase I peptide vaccine trial for the treatment of H3-mutated diffuse midline gliomas
Enthalten in Neurological research and practice Bd. 5, 19.10.2023, Nr. 1, date:12.2023: 1-6
|
|
|
|
67 |
Long-term CSF responses in adult patients with spinal muscular atrophy type 2 or 3 on treatment with nusinersen
Enthalten in Journal of neurology Bd. 272, 14.3.2025, Nr. 4, date:4.2025: 1-17
|
|
|
|
68 |
Longitudinal analysis of quality of life following treatment with Asunercept plus reirradiation versus reirradiation in progressive glioblastoma patients
Enthalten in Journal of neuro-oncology Bd. 145, 2.11.2019, Nr. 3, date:12.2019: 531-540
|
|
|
|
69 |
Loss over 5% of chromosome 1p is a clinically relevant and applicable cut-off for increased risk of recurrence in meningioma
Enthalten in Acta neuropathologica Bd. 148, 8.8.2024, Nr. 1, date:12.2024: 1-4
|
|
|
|
70 |
Neurocognitive functioning and health-related quality of life in adult medulloblastoma patients: long-term outcomes of the NOA-07 study
Enthalten in Journal of neuro-oncology Bd. 148, 4.5.2020, Nr. 1, date:5.2020: 117-130
|
|
Administration
